CHARLES SCHWAB INVESTMENT MANAGEMENT INC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,880
-24.4%
32,0000.0%0.00%
Q4 2022$14,400
-50.3%
32,0000.0%0.00%
Q3 2022$29,000
-21.6%
32,0000.0%0.00%
Q2 2022$37,000
-33.9%
32,0000.0%0.00%
Q1 2022$56,000
-46.2%
32,0000.0%0.00%
Q4 2021$104,000
+188.9%
32,000
+70.8%
0.00%
Q1 2021$36,000
-57.6%
18,733
-49.9%
0.00%
Q4 2020$85,000
+13.3%
37,4240.0%0.00%
Q3 2020$75,00037,4240.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 900,733$1,883,0001.44%
Sio Capital Management, LLC 1,501,998$3,139,0000.92%
CVI Holdings, LLC 704,900$1,473,0000.55%
Perceptive Advisors 8,476,496$17,466,0000.28%
Artal Group S.A. 2,974,000$6,216,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 880,000$1,839,0000.17%
DAFNA Capital Management LLC 275,000$575,0000.17%
J. Goldman & Co LP 1,018,285$2,128,0000.13%
MYDA Advisors LLC 100,000$209,0000.13%
683 Capital Management, LLC 526,466$1,100,0000.09%
View complete list of LEAP THERAPEUTICS INC shareholders